Sign In
Buy CLVS
$0.151
+0 (+0%)
At Close: Apr 19, 2023
Is Clovis Oncology (CLVS) Stock a Solid Choice Right Now?
02:18pm, Thursday, 14'th May 2020
Clovis Oncology (CLVS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Why Clovis Oncology Stock Marched Higher in April
03:00pm, Monday, 11'th May 2020
Shares of small-cap cancer company Clovis Oncology (NASDAQ: CLVS) gained a whopping 33.7% over the course of April, according to data from S&P; Global Market Intelligence. Clovis' stock regained it
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Clovis (CLVS) Q1 Earnings and Revenues Surpass Estimates
03:17pm, Wednesday, 06'th May 2020
Clovis (CLVS) reports first-quarter 2020 results. The company's sole marketed drug, Rubraca, drives revenues. Shares up.
Edited Transcript of CLVS earnings conference call or presentation 5-May-20 8:30pm GMT
03:10pm, Wednesday, 06'th May 2020
Q1 2020 Clovis Oncology Inc Earnings Call
Clovis Oncology (CLVS) Q1 2020 Earnings Call Transcript
03:02pm, Wednesday, 06'th May 2020
Thank you for standing by, and welcome to the Clovis Oncology first-quarter 2020 financial results conference call. Then Dan Muehl, Clovis' chief financial officer, will cover the quarter's financial
Benzinga Pro's Top 5 Stocks To Watch for Wed., May 6, 2020: SNY, GRUB, CLVS, NTDOY, FDS
12:02pm, Wednesday, 06'th May 2020
Today's 5 Stock Ideas: * Sanofi (SNY) \- A play on a potential coronavirus vaccine. A report Tuesday evening suggested the company was in talks with several countries (including the US) related to adv
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
Clovis Oncology (CLVS) Reports Q1 Loss, Tops Revenue Estimates
11:05pm, Tuesday, 05'th May 2020
Clovis (CLVS) delivered earnings and revenue surprises of 0.78% and 1.84%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Clovis Oncology Announces First Quarter 2020 Operating Results
08:05pm, Tuesday, 05'th May 2020
Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter ended March 31, 2020, and provided an update on the Company’s clinical development programs and regulatory and commerci
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 5.)
Arcturus Therapeutics Ltd (...
Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates
01:25pm, Sunday, 03'rd May 2020
April turned out to be a productive month in terms of drug approvals, with the FDA issuing positive verdicts on almost all applications for which decisions were due. The month saw the approval of five
